Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer.

Zhao D, Tan Z, Chen W, Liu S, Wu T, Li X, Xiang Y, Wang H, Lu Z

Open source

DOI
10.2147/bctt.s583235
Published
2026
Container
Breast cancer (Dove Medical Press)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/bctt.s583235,
  title = {Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer.},
  author = {Zhao D and Tan Z and Chen W and Liu S and Wu T and Li X and Xiang Y and Wang H and Lu Z},
  year = {2026},
  journal = {Breast cancer (Dove Medical Press)},
  doi = {10.2147/bctt.s583235},
  url = {https://doi.org/10.2147/bctt.s583235}
}

RIS

TY  - JOUR
TI  - Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer.
AU  - Zhao D
AU  - Tan Z
AU  - Chen W
AU  - Liu S
AU  - Wu T
AU  - Li X
AU  - Xiang Y
AU  - Wang H
AU  - Lu Z
PY  - 2026
JO  - Breast cancer (Dove Medical Press)
DO  - 10.2147/bctt.s583235
UR  - https://doi.org/10.2147/bctt.s583235
ER  - 

APA

D, Z., Z, T., W, C., S, L., T, W., X, L., Y, X., H, W., & Z, L. (2026). Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer.. Breast cancer (Dove Medical Press). https://doi.org/10.2147/bctt.s583235

Source records